177Lu-NeoBOMB1 for GRPR-mediated cancer treatment: the effect of peptide mass on efficacy and safety
S Dalm, E de Blois, J Haeck, G Doeswijk… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Results: Up to now animals were followed 26 d post the first therapeutic injection. At this time
point only 20% of the control animals survived, while 100% of animals in the treatment
groups survived. Average tumor size at this same time point was 1588±435 (n= 2), 380±167 …
point only 20% of the control animals survived, while 100% of animals in the treatment
groups survived. Average tumor size at this same time point was 1588±435 (n= 2), 380±167 …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论